UH1 COBRE PILOT: ROLE OF DNA INTERFERENCE IN DENGUE VIRUS-MOSQUITO INTERACTIONS
UH1 COBRE 试点:DNA 干扰在登革热病毒与蚊子相互作用中的作用
基本信息
- 批准号:8168411
- 负责人:
- 金额:$ 7.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-16 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AedesAntiviral AgentsBindingBiteCellsComputer Retrieval of Information on Scientific Projects DatabaseCulicidaeDengueDengue VirusDrosophila genusEngineeringFundingGrantHandHealthHumanImmunityInfectionInstitutionLeadMammalian CellMediatingMolecular ProfilingNatural ImmunityOrganismPharmaceutical PreparationsPlantsProcessProteinsRNA InterferenceRNA Interference PathwayRNA VirusesRegulator GenesResearchResearch PersonnelResistanceResourcesRoleSmall Interfering RNASmall RNASourceUnited States National Institutes of HealthVaccinesViralViral GenomeViral ProteinsVirusVirus DiseasesVirus Replicationbasecopingresponsevectorvector controlvector mosquitoviral RNAviral detection
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Dengue is the most common vector-borne viral disease in humans. Because of the lack of vaccines and drugs, emerging and resurging of dengue have become increasing threats to human health in tropical and subtropical regions. Dengue virus (DENV), a positive-sense, single-stranded RNA virus, is transmitted to humans through the bite of infected Aedes mosquitoes, including Ae. aegypti and Ae. albopictus. Understanding the molecular interactions between dengue virus and the vector mosquito is the prerequisite for developing effective strategies for vector control. However, little is known about how mosquitoes cope with virus infection and what the innate immunity against viruses is.
RNA interference (RNAi) is a small RNA-mediated gene-regulatory mechanism that is conserved in most eukaryotic organisms. In plants and Drosophila, RNAi has been identified as a natural antiviral immunity. Viruses are both initiators and targets of RNAi, and replicating viral RNAs are recognized by RNAi machinery and processed into viral small interfering RNAs (siRNAs), which direct specific degradation of homologous viral RNAs. On the other hand, viruses encode proteins to suppress RNAi-based antiviral defense to achieve successful infection. In Aedes mosquitoes, engineering RNAi that targets DENV sequences could lead to resistance to DENV infection or inhibition of virus replication and accumulation. However, it's still not clear in mosquitoes if RNAi mechanism functions as a major natural antiviral immunity, and how viruses interact with RNAi pathway.
The objective of this project is to investigate the natural role of RNAi in Aedes mosquito cells in response to DENV infection.
Specific Aim 1. Characterization of small RNAs in DENV-infected Aedes mosquito cells
In plants and Drosophila, RNAi-based antiviral defense can be induced by virus infection, which is correlated with accumulation of abundant siRNAs derived from the silenced viral genome. Viral siRNAs are considered as a molecular signature of the antiviral RNAi in infected cells.
(1) Determine if DENV viral siRNAs accumulate in infected Aedes mosquito cells
(2) Perform ultra-deep sequencing of small RNAs from DENV-infected Aedes mosquito cells
(3) Identify and characterize small RNAs in DENV-infected Aedes mosquito cells
Specific Aim 2. Identification of RNAi suppressors encoded by DENV
Besides the detection of viral siRNAs in infected cells, identification of RNAi suppressors encoded by DENV is another direct evidence to support that RNAi serves as natural antiviral immunity in Aedes mosquito cells.
(1) Determine if DENV infection can inhibit RNAi in Aedes mosquito cells
(2) Identify DENV proteins that can inhibit RNAi in Aedes mosquito cells
(3) Determine if DENV proteins can suppress RNAi in mammalian cells
(4) Perform mechanistic analysis of RNAi suppression by DENV proteins
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
登革热是人类最常见的病媒传播的病毒性疾病。由于缺乏疫苗和药物,登革热的出现和死灰复燃已成为热带和亚热带地区日益严重的威胁人类健康的问题。登革病毒(DENV)是一种正义单链RNA病毒,通过感染的伊蚊(包括Ae.埃及伊蚊和埃及伊蚊。白纹伊蚊了解登革病毒与蚊媒之间的分子相互作用是制定有效的病媒控制策略的先决条件。然而,人们对蚊子如何科普病毒感染以及对病毒的先天免疫是什么知之甚少。
RNA干扰(RNAi)是一种小RNA介导的基因调控机制,在大多数真核生物中是保守的。在植物和果蝇中,RNAi已被确定为天然的抗病毒免疫。病毒既是RNAi的启动子又是RNAi的靶点,复制的病毒RNA被RNAi机制识别并加工成病毒小干扰RNA(siRNA),其指导同源病毒RNA的特异性降解。另一方面,病毒编码蛋白质来抑制基于RNAi的抗病毒防御,以实现成功感染。在伊蚊中,靶向DENV序列的工程RNAi可能导致对DENV感染的抗性或抑制病毒复制和积累。然而,目前尚不清楚RNAi机制是否是蚊子的主要天然抗病毒免疫机制,以及病毒如何与RNAi途径相互作用。
该项目的目的是研究RNAi在伊蚊细胞中响应DENV感染的自然作用。
具体目标1。 登革病毒感染伊蚊细胞中小分子RNA的特征
在植物和果蝇中,病毒感染可以诱导基于RNAi的抗病毒防御,这与来自沉默的病毒基因组的丰富siRNA的积累相关。病毒siRNA被认为是感染细胞中抗病毒RNAi的分子标记。
(1)确定DENV病毒siRNA是否在感染的伊蚊细胞中积累
(2)对来自DENV感染的伊蚊细胞的小RNA进行超深度测序
(3)DENV感染的伊蚊细胞中小RNA的鉴定和表征
具体目标2。 DENV编码的RNAi抑制子的鉴定
除了在感染细胞中检测到病毒siRNA外,DENV编码的RNAi抑制子的鉴定是支持RNAi在伊蚊细胞中作为天然抗病毒免疫的另一个直接证据。
(1)确定DENV感染是否可以抑制伊蚊细胞中的RNAi
(2)鉴定可抑制伊蚊细胞中RNAi的DENV蛋白
(3)确定DENV蛋白是否可以抑制哺乳动物细胞中的RNAi
(4)通过DENV蛋白进行RNAi抑制的机制分析
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hongwei Li其他文献
Hongwei Li的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hongwei Li', 18)}}的其他基金
P3: ROLE OF MIRNAS IN DENGUE IMMUNOPATHOGENESIS
P3:Mirnas 在登革热免疫发病机制中的作用
- 批准号:
8360755 - 财政年份:2011
- 资助金额:
$ 7.49万 - 项目类别:
UH1 COBRE PILOT: ROLE OF DNA INTERFERENCE IN DENGUE VIRUS-MOSQUITO INTERACTIONS
UH1 COBRE 试点:DNA 干扰在登革热病毒与蚊子相互作用中的作用
- 批准号:
7610522 - 财政年份:2007
- 资助金额:
$ 7.49万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 7.49万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 7.49万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 7.49万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 7.49万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 7.49万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 7.49万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 7.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 7.49万 - 项目类别:














{{item.name}}会员




